The current valuation score of Verrica Pharmaceuticals Inc is 7.42, ranking 127 out of 157 in the Pharmaceuticals industry. Its current P/E ratio is -5.10, which is -99.43% below the recent high of -0.03 and -30.67% above the recent low of -6.66.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.